LT - Rekombinantinis FSH, įskaitant alfa 2,3- ir alfa 2,6-sialinimą
EN - RECOMBINANT FSH INCLUDING ALPHA 2,3- AND ALPHA 2,6-SIALYLATION
Legal status
Patent revoked (after opposition at EPO)
Bibliographic data
Indications of the International Patent Classification (IPC)
| (51) |
INT.CL. |
A61K 38/00 |
(2006.01) |
|
|
C07K 14/59 |
(2006.01) |
European patent
| (11) |
Number of the document |
2268666 |
| (13) |
Kind of document |
T |
| (96) |
European patent application number |
09733497.3 |
|
Date of filing the European patent application |
2009-04-16 |
| (97) |
Date of publication of the European application |
2011-01-05 |
| (45) |
Date of publication and mention of the grant of the patent |
2014-03-12
|
| (46) |
Date of publication of the claims translation |
2014-06-25
|
PCT application
| (86) |
Number |
PCT/GB2009/000978 |
|
Date |
2009-04-16 |
PCT application publication
| (87) |
Number |
WO 2009/127826 |
|
Date |
2009-10-22 |
Priority applications
| (30) |
Number |
Date |
Country code |
|
45424 P |
2008-04-16
|
US |
|
08251528 |
2008-04-25
|
EP |
Inventors
| (72) |
COTTINGHAM, Ian, GB
PLAKSIN, Daniel, CH
WHITE, Richard, Boyd, US
|
Grantee
| (73) |
Ferring B.V.,
Polaris Avenue 144, 2132 JX Hoofddorp,
NL
|
Attorney or representative
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
Title
| (54) |
Rekombinantinis FSH, įskaitant alfa 2,3- ir alfa 2,6-sialinimą |
| |
RECOMBINANT FSH INCLUDING ALPHA 2,3- AND ALPHA 2,6-SIALYLATION |
Last renewal fee
|
Payment date |
Validity (years) |
Amount |
|
2019-04-16 |
11 |
289.00
EUR
|
Legal status
|
Patent revoked (after opposition at EPO)
|
|
|
Invalidation date |
2020-02-14 |
